Skip to main content

Table 2 Estimation results for the program effects on the logarithm of individual income

From: Are there employment and income gains of a national breast cancer screening program?

 

Ages 47–53

 

Ages 49 and 51

Coef.

Std.Err.

Coef.

Std.Err.

Panel A: Difference from the baseline for BC diagnosed women, Eq. (1)

 No screening program, β0

−0.057***

(0.008)

− 0.052***

(0.012)

 Screening program, β1

−0.048***

(0.006)

− 0.044***

(0.010)

 Program effect, Eq. (1): (β1 − β0)

0.009

(0.010)

0.008

(0.016)

Panel B: Differences from the baseline for BC diagnosed women by time since diagnosis, Eq. (2)

No screening program, \({\beta}_0^k\) s

  In year of diagnosis

− 0.027**

(0.013)

−0.028**

(0.013)

  1 year after diagnosis

−0.082***

(0.014)

−0.076***

(0.016)

  2 years after diagnosis

−0.068***

(0.014)

−0.068***

(0.016)

  3 years after diagnosis

−0.057***

(0.015)

−0.064***

(0.021)

  4 years after diagnosis

−0.050***

(0.018)

−0.056**

(0.027)

  5 years after diagnosis

−0.030

(0.019)

−0.021

(0.024)

  6 years after diagnosis

−0.022

(0.022)

−0.062

(0.030)

Screening program, \({\beta}_1^k\) s

  In year of diagnosis

−0.032***

(0.010)

−0.028***

(0.010)

  1 year after diagnosis

−0.062***

(0.011)

−0.059***

(0.012)

  2 years after diagnosis

−0.046***

(0.011)

−0.058***

(0.015)

  3 years after diagnosis

−0.041***

(0.012)

−0.045***

(0.015)

  4 years after diagnosis

−0.053***

(0.014)

−0.040*

(0.021)

  5 years after diagnosis

−0.061***

(0.017)

−0.057**

(0.027)

  6 years after diagnosis

−0.040

(0.022)

−0.060

(0.042)

Program effect, \(\left({\beta}_1^k-{\beta}_0^k\right)\) s

  In year of diagnosis

−0.005

(0.016)

0.000

(0.017)

  1 year after diagnosis

0.020

(0.017)

0.016

(0.020)

  2 years after diagnosis

0.021

(0.018)

0.010

(0.022)

  3 years after diagnosis

0.016

(0.019)

0.018

(0.025)

  4 years after diagnosis

−0.003

(0.023)

0.016

(0.034)

  5 years after diagnosis

−0.030

(0.025)

−0.036

(0.036)

  6 years after diagnosis

−0.018

(0.031)

0.002

(0.051)

Panel C: Specification tests (p-values)

 No program effects

0.052*

 

0.668

 

 No time since diagnosis effects

0.000***

 

0.001***

 

 No age at diagnosis effects

0.651

   

 Common trend before the time of diagnosis

0.002***

 

0.255

 

 Hausman test (H0: random effects)

0.000***

 

0.000***

 

R2 (within)

0.024

 

0.024

 

Number of observations

1,086,034

 

1,042,603

 

Number of years

7

 

7

 

Number of women

206,186

 

199,627

 
  1. Notes. BC Breast cancer. The models control for year, age, household size, number of adults, and for panel C, age at diagnosis. For Panel C: No program effects, H0: \(\left({\beta}_1^0-{\beta}_0^0\right)=..\left({\beta}_1^6-{\beta}_0^6\right)=0\); No time since diagnosis effects, H0: \({\beta}_0^0=..={\beta}_0^6\), \({\beta}_1^0=..={\beta}_1^6\), No age at diagnosis effects, H0: γ47 = γ48, γ50 = γ52 = γ53. The standard errors are clustered by individual. Levels of significance: *** p < 0.01, ** p < 0.05, * p < 0.10